The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

A group of 15 states have reached a tentative new deal that would require them to set aside hundreds of millions of dollars ...

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

This settlement is among the largest in recent years as lawsuits seek to hold companies accountable for the US opioid epidemic.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

More than $7 billion could be on the way to families affected by the opioid crisis, but New Hampshire hasn't decided whether to join the new settlement.

Everything in my life is shaped by a company that put profits over human lives,” one woman who became addicted to OxyContin ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller.

Purdue Pharma and the Sackler family reach a $7.4 billion settlement over their role in the US opioid crisis. The deal, increasing the previous offer by $1.4 billion, ends Sackler control of Purdue ...